
Source briefing
Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Date of authorisation: 18/09/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Date of authorisation: 18/09/2026, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 18, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Pregabalin Viatris Pharma (previously Pregabalin Pfizer), pregabalin, Date of authorisation: 10/04/2014, Revision: 39, Status: Authorised
Human medicines European public assessment report (EPAR): Pregabalin Viatris Pharma (previously Pregabalin Pfizer), pregabalin, Date of authorisation: 10/04/2014, Revision: 39, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Susvimo, ranibizumab, Date of authorisation: 18/09/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Susvimo, ranibizumab, Date of authorisation: 18/09/2026, Status: Authorised
Read →
Source briefing
European standards of prevention and care: Module on antenatal screening for HIV, hepatitis B and syphilis
The global community has committed to eliminating vertical transmission of HIV, hepatitis B virus (HBV) and syphilis as a public health priority. This global commitment encourages countries to provide the most effective, high-quality and person-centred care available to…
Read →
Source briefing
Evaluation of the tuberculosis notification impact from an intermediary-facilitated public–private mix intervention in Viet Nam: A population-level quasi-experimental study
by Luan Nguyen Quang Vo, Thuy Thi Thu Dong, Huy Ba Huynh, Binh Anh Luong, Huong Thi Lan Mo, Andrew James Codlin, Rachel Forse, Thuy Doan To Mai, Lan Phuong Nguyen, Jacob Creswell, Luong Van Dinh, Hoa Binh…
Read →
Source briefing
First European Medicines Agency (EMA) and Active Pharmaceutical Ingredients Committee (APIC) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 2 September 2026, 15:30 (CEST) to 2 September 2026, 17:30 (CEST)
First European Medicines Agency (EMA) and Active Pharmaceutical Ingredients Committee (APIC) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 2 September 2026, 15:30 (CEST) to 2 September 2026, 17:30 (CEST)
Read →
Source briefing
Real-world data collection in Duchenne muscular dystrophy: Joint Heads of Medicines Agencies (HMA) / European Medicines Agency (EMA) multistakeholder workshop, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 September 2026, 09:00 (CEST) to 25 September 2026, 17:30 (CEST)
Real-world data collection in Duchenne muscular dystrophy: Joint Heads of Medicines Agencies (HMA) / European Medicines Agency (EMA) multistakeholder workshop, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 September 2026, 09:00 (CEST) to 25 September 2026,…
Read →
Source briefing
Trump’s Latest Media Attacks Again Hit Women Journalists
Click to expand Image MS NOW White House Correspondent Akayla Gardner prepares for a television report on a street corner outside the White House grounds in Washington, DC, on September 21, 2026. © 2026 Andrew Thomas/NurPhoto via AP…
Read →
Source briefing
Regulatory Perspectives on Herbal Medicinal / Botanical Drug Product Development: Joint FDA / EMA Workshop, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 September 2026, 10:00 (CEST) to 25 September 2026, 13:00 (CEST)
Regulatory Perspectives on Herbal Medicinal / Botanical Drug Product Development: Joint FDA / EMA Workshop, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 September 2026, 10:00 (CEST) to 25 September 2026, 13:00 (CEST)
Read →